摘要
糖尿病神经病变的发病机制到目前为止还尚未完全明确,晚期糖基化终产物(AGEs)的过多形成及与其受体(RAGE)的相互作用是其重要机制之一。本文从AGEs在外周神经中的形成特点、RAGE的表达分布和调节、AGEs-RAGE系统在糖尿病神经病变发病中的作用及其可能机制等方面作了综述,并对可通过阻断AGEs-RAGE系统而治疗糖尿病神经病变的药物进展作了概括。
出处
《国际神经病学神经外科学杂志》
2007年第3期270-273,共4页
Journal of International Neurology and Neurosurgery
参考文献21
-
1Yamamoto Y,Yamagishi S,Yonekura H,et al.Roles of the AGE-RAGE system in vascular injury in diabetes.Ann N Y Acad Sci,2000,902(1):163-170.
-
2Misur I,Zarkovic K,Barada A,et al.Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy.Acta Diabetol,2004,41 (4):158-166.
-
3Wada R,Nishizawa Y,Yagihashiet N,et al.Effects of OPB -9195,anti -glycation agent,on experimental diabetic neuropathy.Eur J Clin Invest,2001,31 (6):513-520.
-
4Stracke H,Hammes H P,Werkmann D,et al.Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats.Exp Clin Endocrinol Diabetes,2001,109(6):330-336.
-
5Nakamura K,Yamagishi S,Nakamura Y,et al.Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-Ⅱ-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.Microvasc Res,2005,70 (3):137-141.
-
6Di Loreto S,Caracciolo V,Colafarina S,et al.Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1 beta and nerve growth factor in cultured hippocampal neuronal cells.Brain research,2004,1006(2):157-167.
-
7Nitti M,d'Abramo C,Traverso N,et al.Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons.Free Radic Biol Med,2005,38(7):846-856.
-
8Sekido H,Suzuki T,Jomori T,et al.Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells.Biochem Biophys Res Commun,2004,320(1):241-248.
-
9Meerwaldt R,Links T P,Graaff R,et al.Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.Diabetologia,2005,48(8):1637-1644.
-
10Cellek S,Qu W,Schmidt AM,et al.Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro:A new insight into selective nitrergic neuropathy in diabetes.Diabetologia,2004,47(2):331-339.
同被引文献26
-
1汤正义.糖尿病周围神经病变客观检查方法的应用和研究现状[J].内科理论与实践,2007,2(3):157-159. 被引量:12
-
2Boulton A J, Vinik AI, Arezzo JC, et al. Dibetic neuropathies: a statement by the American Diabetes Association. Diabetes Care, 2005, 28(4): 956-962.
-
3Natalia VB, Alexander DV. Reprint of The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res, 2009, 77 ( 1 ) : 64-69.
-
4Giaccari A, Sorice G, Muscogiuri G, et al. Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes-mechanisms and potentials for treatment. Nutr Metab Cardiovase Dis, 2009, 19(5) : 365-377.
-
5Anuran C, John DC. Endothelial nitricoxide (NO) and it spathophy siologic regulation. Vascul Pharmacol, 2008, 49 (4-6):134-140.
-
6Sunil P, Mahendra K. NO/peroxynitrite dynamics of highglucose-exposed HUVECs: Chemiluminescent measurement computationmodel. Microvasc Res, 2009, 78 ( 2 ) : 191 -198.
-
7Tetsuya H, Tatsuro I, Husni MC, et al. Endothelial cell-selective adhesion molecule regulates albuminuria indiabetic nephropathy. Microvascu Res, 2009, 77 ( 3 ) : 348-355.
-
8Daniela M, Karla L, Frank H, et al. Impact of diabetic serum on endothelial cells: An in-vitro-analysis of endothelial dysfunction in diabetes mellitus type 2. Bioehem Biophys Res Commun, 2007, 362(2): 238-244.
-
9Gabriela O, Jorge P, Glaxo SK, et al. The Pathologic Continuum of Diabetic Vascular Disease. J Am Coll Cardiol, 2009, 2(3) : 35-42.
-
10Josefa G, Josep MM, Francesc M, et al. Oxidized to non- oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metabol Cardiovasc Dis, 2008, 18(5) : 380-387.
二级引证文献10
-
1罗净.电针联合穴位注射治疗2型糖尿病周围神经病变的临床观察[J].世界最新医学信息文摘,2020(96):205-205. 被引量:1
-
2穆晓红,刘铜华.糖尿病周围神经病变动物模型建立方法及发病机制研究进展[J].国际中医中药杂志,2011,33(4):358-361. 被引量:3
-
3王国利,雷燕,王铭.从络病的角度谈血管老化[J].中华中医药杂志,2011,26(9):2055-2058. 被引量:15
-
4吕翠岩,刘铜华.糖尿病周围神经病变发病机制研究进展[J].吉林中医药,2012,32(11):1179-1182. 被引量:17
-
5余青云,洪铭范,刘爱群,程静,叶建华,马承红.糖尿病患者瞬目反射变化的特点及影响因素[J].广东医学,2013,34(23):3591-3593.
-
6沈昊,金洁,陆赵阳,沈国荣.血浆小而密低密度脂蛋白胆固醇水平与颈总动脉内膜中膜厚度的相关性[J].中国动脉硬化杂志,2014,22(3):261-264. 被引量:6
-
7吕翠岩,张胜容,徐暾海,孙文,贾晓蕾,赵文景,张竹华,蔡朕,郑桂敏,孟元,赵静,王晖,陈洋子,刘铜华.复方中药糖痹康对糖尿病周围神经病变大鼠PAI-1的影响[J].北京中医药,2016,35(3):222-224. 被引量:3
-
8周昊玲,颜灿群.糖尿病周围神经病变的研究进展[J].西南军医,2017,19(1):81-83. 被引量:24
-
9陈翠芝,王亚琼,裴友翠.足痹通络方治疗糖尿病性周围神经病变的疗效观察[J].世界中医药,2017,12(4):776-779. 被引量:3
-
10连心逸,刘文科,田佳星,史丽伟,倪博然,倪青.2型糖尿病性周围神经病合并胰岛素抵抗病案--仝小林院士教学查房实录[J].长春中医药大学学报,2024,40(3):237-242.
-
1孟庆元,林炜栋,陈向芳.AGE-RAGE系统与糖尿病足综合征的发病机制及治疗进展[J].药学服务与研究,2009,9(2):118-121. 被引量:17
-
2冯云飞,沈建国.AGE-RAGE系统在糖尿病视网膜病变中的作用[J].国际内分泌代谢杂志,2007,27(5):342-344. 被引量:1
-
3叶莉莉,徐星铭.狼疮性肾炎患者HMGB1和RAGE的表达及意义[J].安徽医科大学学报,2015,50(4):533-537. 被引量:10
-
4姚美芬(综述),沈建国(审校).AGE—RAGE系统及氧化应激与糖尿病肾病[J].国际泌尿系统杂志,2008,28(4):524-527. 被引量:3
-
5邹玉婷,沈建国.AGEs/AGE-RAGE与糖尿病血管并发症[J].浙江医学,2008,30(3):298-300. 被引量:5
-
6穆传深,邵传章.耐甲氧西林金黄色葡萄球菌耐药机制及治疗药物进展[J].药物分析杂志,1995,15(A01):572-575.
-
7黄峰,朱鹏立,林帆,袁音.替米沙坦对自发性高血压大鼠脑组织AGEs-RAGE表达的影响[J].福建医药杂志,2015,37(4):12-14.
-
8黄欣.治疗肥胖的药物进展[J].山东医药工业,1999,18(2):19-20.
-
9王春阁,张弋.治疗肝移植术后乙肝复发的药物进展[J].中国临床药理学与治疗学,2002,7(3):283-285. 被引量:5
-
10陈亮,杨华章.糖尿病口服药物进展及其临床应用[J].辽宁实用糖尿病杂志,2002,10(2):54-56. 被引量:17